Nickell JR

First name:
Nickell
Suffix:
JR
Meyer, A. C., Horton, D. B., Neugebauer, N. M., Wooters, T. E., Dwoskin, L. P., & Bardo, M. T. (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033
View
Beckmann, J. S., Siripurapu, K. B., Horton, D. B., Denehy, E. D., Vartak, A., Crooks, P. A., et al. (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal Of Pharmacology And Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742
View
Lee, N. R., Zheng, G., Leggas, M., Crooks, P. A., Bardo, M. T., Dwoskin, L. P., et al. (2019). GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal Of Pharmacology And Experimental Therapeutics, 371(2), 526-543. https://doi.org/10.1124/jpet.119.258699
View